Medtronic is sponsoring a series of new clinical tests of its controversial genetically engineered bone-growth product Infuse in an effort to gather long-term data about the optimal dose of the ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Back to Healio TORONTO — Investigators at the Cleveland ...
Please provide your email address to receive an email when new articles are posted on . Romosozumab as a first treatment produces ‘substantial gains’ in hip and lumbar spine bone mineral density ...
CARLSBAD, Calif., Oct. 5, 2010 (GLOBE NEWSWIRE) -- Alphatec Holdings, Inc. (Nasdaq:ATEC), the parent company of Alphatec Spine, Inc., a medical device company that designs, develops, manufactures and ...
The vertebral bones that form the spine are derived from a distinct type of stem cell that secretes a protein favoring tumor metastases, according to a study led by researchers at Weill Cornell ...
"Metabolic bone disease is a major public health concern. In 2010, the U.S. prevalence of low bone mineral density in adults 50 and older was 44 percent, and 10.3 percent had a diagnosis of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback